Location: Dallas, TX
CIK: 0001791827 · Show all filings
Period: Q2 2025 (← Previous) (Next →)
Filing Date: Aug 14, 2025
Total Value: $502M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| CGON | CG ONCOLOGY INC | 1,499,942 | $39M | 7.8% | $34.23 | -29.6% | COM | 156944100 |
| BSX | BOSTON SCIENTIFIC CORP | 321,800 | $34.56M | 6.9% | $49.10 | +106.1% | COM | 101137107 |
| NTRA | NATERA INC | 199,300 | $33.67M | 6.7% | $95.53 | +63.1% | COM | 632307104 |
| DNTH | DIANTHUS THERAPEUTICS INC | 1,742,902 | $32.47M | 6.5% | $18.10 | +3.7% | COM | 252828108 |
| EXAS | EXACT SCIENCES CORP | 355,000 | $18.86M | 3.8% | $55.79 | -8.9% | COM | 30063P105 |
| THC | TENET HEALTHCARE CORP | 106,000 | $18.66M | 3.7% | $82.94 | +81.5% | COM NEW | 88033G407 |
| DXCM | DEXCOM INC | 210,500 | $18.37M | 3.7% | $108.16 | -27.5% | COM | 252131107 |
| DHR | DANAHER CORPORATION | 89,700 | $17.72M | 3.5% | $205.28 | -6.0% | COM | 235851102 |
| HNGE | HINGE HEALTH INC | 322,344 | $16.68M | 3.3% | $40.42 | 0.0% | CL A | 433313103 |
| ISRG | INTUITIVE SURGIVAL INC | 27,100 | $14.73M | 2.9% | $522.87 | 0.0% | COM NEW | 46120E602 |
| GMAB | GENMAB A/S | 650,000 | $13.43M | 2.7% | $20.66 | — | SPONSORED ADS | 372303206 |
| RGEN | REPLIGEN CORP | 106,500 | $13.25M | 2.6% | $127.25 | 0.0% | COM | 759916109 |
| TMO | THERMO FISHER SCIENTIFIC INC | 29,600 | $12M | 2.4% | $475.70 | -12.3% | COM | 883556102 |
| TEVA | TEVA PHARMACEUTICAL INDS LTD | 689,500 | $11.56M | 2.3% | $15.79 | — | SPONSORED ADS | 881624209 |
| JBIO | JADE BIOSCIENCES INC | 1,127,186 | $11.26M | 2.2% | $33.31 | 0.0% | COM NEW | 008064206 |
| PHAT | PHATHOM PHARMACEUTICALS INC | 1,064,500 | $10.21M | 2.0% | $16.93 | -67.3% | COM | 71722W107 |
| UNH | UNITEDHEALTH GROUP INC | 32,000 | $9.983M | 2.0% | $548.30 | -31.6% | COM | 91324P102 |
| MCK | MCKESSON CORP | 13,500 | $9.893M | 2.0% | $703.74 | 0.0% | COM NEW | 58155Q103 |
| AXSM | AXSOME THERAPEUTICS INC | 94,500 | $9.865M | 2.0% | $65.19 | +62.4% | COM | 05464T104 |
| COR | CENCORA INC | 32,800 | $9.835M | 2.0% | $249.56 | +14.9% | COM | 03073E105 |
| HQY | HEALTHEQUITY INC | 92,000 | $9.638M | 1.9% | $101.38 | -6.5% | COM | 42226A107 |
| EHC | ENCOMPASS HEALTH CORP | 74,000 | $9.075M | 1.8% | $113.68 | 0.0% | COM | 29261A100 |
| RVMD | REVOLUTION MEDICINES INC | 228,600 | $8.41M | 1.7% | $31.27 | +22.9% | COM | 76155X100 |
| — | AKERO THERAPEUTICS INC | 134,000 | $7.15M | 1.4% | $42.50 | — | COM | 00973Y108 |
| OMDA | OMADA HEALTH INC | 390,600 | $7.148M | 1.4% | $17.31 | 0.0% | COM | 68170A108 |
| BEAM | BEAM THERAPEUTICS INC | 409,400 | $6.964M | 1.4% | $26.20 | -33.5% | COM | 07373V105 |
| HUM | HUMANA INC | 27,600 | $6.748M | 1.3% | $348.89 | -29.3% | COM | 444859102 |
| CATX | PERSPECTIVE THERAPEUTICS INC | 1,858,596 | $6.394M | 1.3% | $14.32 | -81.6% | COM NEW | 46489V302 |
| OGN | ORGANON & CO | 640,000 | $6.195M | 1.2% | $14.31 | -28.4% | COM | 68622V106 |
| BBIO | BRIDGEBIO PHARMA INC | 140,000 | $6.045M | 1.2% | $34.95 | +4.1% | COM | 10806X102 |
| INSM | INSMED INC | 59,000 | $5.938M | 1.2% | $48.37 | +58.1% | COM PAR $.01 | 457669307 |
| MDGL | MADRIGAL PHARMACEUTICALS INC | 19,000 | $5.75M | 1.1% | $297.95 | 0.0% | COM NEW | 558868105 |
| RARE | ULTRAGENYX PHARMACEUTICAL IN | 154,000 | $5.599M | 1.1% | $51.17 | -29.6% | COM | 90400D108 |
| CNTX | CONTEXT THERAPEUTICS INC | 7,477,255 | $4.899M | 1.0% | $1.72 | -58.3% | COM | 21077P108 |
| ORKA | ORUKA THERAPEUTICS INC | 352,124 | $3.947M | 0.8% | $34.79 | -70.0% | COM | 687604108 |
| IMUX | IMMUNIC INC | 5,615,811 | $3.917M | 0.8% | $1.22 | -24.8% | COM | 4525EP101 |
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | 268,000 | $3.757M | 0.7% | $14.02 | 0.0% | COM | 03969K108 |
| DOCS | DOXIMITY INC | 60,000 | $3.68M | 0.7% | $63.15 | -11.6% | CL A | 26622P107 |
| XENE | XENON PHARMACEUTICALS INC | 107,891 | $3.377M | 0.7% | $37.48 | -13.0% | COM | 98420N105 |
| — | VERONA PHARMA PLC | 33,800 | $3.197M | 0.6% | $94.58 | — | SPONSORED ADS | 925050106 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 340,000 | $3.184M | 0.6% | $18.49 | -40.5% | Call | 87164F105 |
| QURE | UNIQURE NV | 207,000 | $2.886M | 0.6% | $9.06 | +48.4% | SHS | N90064101 |
| APGE | APOGEE THERAPEUTICS INC | 65,000 | $2.823M | 0.6% | $38.04 | 0.0% | COM | 03770N101 |
| SLNO | SOLENO THERAPEUTICS INC | 32,000 | $2.681M | 0.5% | $48.69 | +53.7% | COM | 834203309 |
| CAH | CARDINAL HEALTH INC | 15,000 | $2.52M | 0.5% | $147.12 | 0.0% | COM | 14149Y108 |
| SPRY | ARS PHARMACEUTICALS INC | 140,000 | $2.443M | 0.5% | $14.43 | 0.0% | COM | 82835W108 |
| KZR | KEZAR LIFE SCIENCES INC | 502,600 | $2.302M | 0.5% | $7.45 | -42.4% | COM NEW | 49372L209 |
| NTLA | INTELLIA THERAPEUTICS INC | 232,000 | $2.176M | 0.4% | $8.21 | 0.0% | COM | 45826J105 |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 39,000 | $1.841M | 0.4% | $40.73 | 0.0% | A ORD | 61559X104 |
| ARVN | ARVINAS INC | 243,162 | $1.79M | 0.4% | $47.79 | -84.6% | COM | 04335A105 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 150,000 | $1.405M | 0.3% | $18.49 | -40.5% | COM | 87164F105 |
| SCYX | SCYNEXIS INC | 1,228,910 | $829K | 0.2% | $2.82 | -68.9% | COM NEW | 811292200 |
| KPTI | KARYOPHARM THERAPEUTICS INC | 134,566 | $580K | 0.1% | $8.54 | -42.5% | COM NEW | 48576U205 |
| ALT | ALTIMMUNE INC | 105,000 | $406K | 0.1% | $5.41 | 0.0% | COM NEW | 02155H200 |
| ELVN | ENLIVEN THERAPEUTICS INC | 11,300 | $227K | 0.0% | $21.52 | -12.0% | COM | 29337E102 |
| RVPH | REVIVA PHARMACEUTICALS HOLDING | 138,000 | $52,592 | 0.0% | $1.57 | -50.5% | COM | 76152G100 |